Now live: Pro — the full 13F research suite for serious investorsSee pricing →
COURAGE CAPITAL MANAGEMENT LLC

Q4 2023 · 13F-HR

COURAGE CAPITAL MANAGEMENT LLCholdings as filed

Filed 2024-02-12 · accession 0001567619-24-000150

$24,775
Reported value
11
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
19249HAB9Coherus Biosciences Inc$4,25417.2%7,500,000CommonSOLE
85207H104PHYSSprott Physical Gold Trust$4,21317.0%264,500CommonSOLE
30050BAD3EVH 1.5 10/15/25Evolent Health Inc$3,92515.8%3,434,000CommonSOLE
38150K103AAAUGoldman Sachs Physical Gold$3,76515.2%184,254CommonSOLE
30303M102METAMeta Platforms Inc$3,18612.9%9,000CommonSOLE
444859102HUMHumana Inc$1,5576.28%3,400CommonSOLE
22822V101CCICrown Castle Intl$1,3825.58%12,000CommonSOLE
464285204IAUiShares Gold Trust$1,0934.41%28,000CommonSOLE
02079K107GOOGAlphabet Inc Class C$7753.13%5,500CommonSOLE
478160104JNJJohnson & Johnson Inc$3131.26%2,000CommonSOLE
369550108GDGeneral Dynamics Corp$3121.26%1,200CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.